Workflow
中牧股份:收到非洲猪瘟亚单位疫苗临床试验批件
CAHICCAHIC(SH:600195) news flash·2025-07-17 08:29

Core Viewpoint - Zhongmu Co., Ltd. has received clinical trial approval for its African swine fever subunit vaccine from the Ministry of Agriculture and Rural Affairs, indicating progress in its vaccine development efforts [1] Group 1: Company Developments - The vaccine is aimed at preventing African swine fever virus infections, showcasing the company's commitment to addressing significant agricultural health issues [1] - The company has invested approximately 46.24 million yuan in research and development for the vaccine in collaboration with research institutions in 2023 [1] Group 2: Industry Context - The development of the vaccine highlights the long and uncertain process from research to market, emphasizing the challenges faced in the pharmaceutical and agricultural sectors [1] - Successful completion of clinical trials and subsequent regulatory approval are necessary steps before the vaccine can be marketed and sold [1]